CTLA4 and non-small cell lung carcinoma: Finally, our analysis using sequencing data from a homologous mouse immunotherapy cohort revealed high IL-35 expression as well as the core pathway Tight junction targeted by Dendrobium houshanense, activation of NSCLC against the negative effects of ICIs treatment such as PD-1/PD-L1, and anti-CTLA-4.